U.S. Health Secretary Robert F. Kennedy Jr. has named eight new members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), following the abrupt dismissal of all 17 prior members. The newly appointed panel includes several figures known for expressing skepticism about vaccines, particularly mRNA technology.
Among the new appointees is Robert Malone, a vocal critic of mRNA COVID-19 vaccines and an ally of Kennedy’s "Make America Healthy Again" movement. Other members include Joseph Hibbeln, Martin Kulldorff, Retsef Levi, Cody Meissner, James Pagano, Vicky Pebsworth, and Michael Ross—some of whom have ties to prior CDC or FDA vaccine panels, while others have promoted views critical of current vaccination practices.
Kennedy, who has long challenged vaccine safety despite scientific consensus, claimed the former panel had conflicts of interest, although he did not provide specific evidence. He emphasized the reshuffle was meant to “restore public trust in vaccine science.”
The new ACIP members will participate in the committee’s June 25–27 meeting, where decisions are expected on vaccine recommendations for flu shots and the 2025–26 COVID-19 boosters. The meeting agenda has yet to be released.
The move sparked market reactions: Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) shares dipped slightly, while Novavax (NASDAQ:NVAX), which produces a non-mRNA COVID-19 vaccine, saw a marginal rise.
Concerns remain about the vetting process for the new members. Some, like Pebsworth and Meissner, have served on FDA advisory committees, while others, such as Levi and Kulldorff, have made controversial statements questioning mRNA vaccine safety.
Despite FDA confirmation that mRNA vaccines are safe and effective, Kennedy’s overhaul has intensified the national debate on vaccine policy and public health strategy.


Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Iran-U.S. Negotiations: Tehran Reviews American Peace Proposal Amid Ongoing Gulf Conflict
G7 Foreign Ministers Gather in France Amid Global Tensions and U.S. Policy Uncertainty
Trump Administration Opens Two New Investigations Into Harvard Over Discrimination and Antisemitism
Denmark Election 2025: Social Democrats Suffer Historic Losses Amid Migration and Cost-of-Living Tensions
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Maduro Faces Rare Narcoterrorism Charges in U.S. Court
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
US-Iran Ceasefire Talks Underway: What You Need to Know
Kristi Noem Ends Western Hemisphere Tour in Diminished Role After DHS Firing
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 



